BIOHM ABSORB

Serial Number 97160703
606

Registration Progress

Application Filed
Dec 7, 2021
Under Examination
Oct 11, 2022
Approved for Publication
Aug 16, 2022
Published for Opposition
Aug 16, 2022
Registered

Basic Information

Serial Number
97160703
Deadline
July 12, 2025
Description
Trademark Application Revival Due
Filing Date
December 7, 2021
Published for Opposition
August 16, 2022
Abandonment Date
May 12, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 12, 2025
Classes
005

Rights Holder

BIOHM HEALTH INC.

03
Address
425 LITERARY RD.
SUITE 100
CLEVELAND, OH 44113

Ownership History

Biohm Health LLC

Original Applicant
16
Cleveland, OH

Biohm Health LLC

Owner at Publication
16
Cleveland, OH

BIOHM HEALTH INC.

New Owner After Publication #1
03
CLEVELAND, OH

Legal Representation

Attorney
Brian E. Turung
USPTO Deadlines 1 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
EXAMINER AMENDMENT
Examiner's Amendment Completed
CNEAR Jul 29, 2022 1074 days overdue Low No

Application History

40 events
Date Code Type Description
May 12, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 12, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 24, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 24, 2024 EX4G S SOU EXTENSION 4 GRANTED
Oct 14, 2024 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION
Oct 14, 2024 PETG O PETITION TO REVIVE-GRANTED
Oct 14, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED
Oct 14, 2024 NREV E NOTICE OF REVIVAL - E-MAILED
Oct 11, 2024 EXT4 S SOU EXTENSION 4 FILED
Apr 10, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 9, 2024 EXT3 S SOU EXTENSION 3 FILED
Apr 9, 2024 EX3G S SOU EXTENSION 3 GRANTED
Apr 9, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 13, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 11, 2023 EX2G S SOU EXTENSION 2 GRANTED
Oct 11, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 11, 2023 EXT2 S SOU EXTENSION 2 FILED
Apr 21, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 20, 2023 EX1G S SOU EXTENSION 1 GRANTED
Apr 19, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 14, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 6, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 6, 2023 EXT1 S SOU EXTENSION 1 FILED
Oct 11, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 16, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 16, 2022 PUBO A PUBLISHED FOR OPPOSITION
Jul 27, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 14, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 14, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jul 14, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED
Jul 14, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 14, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED
Jul 13, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 12, 2022 GNRT F NON-FINAL ACTION E-MAILED
Jan 12, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 12, 2022 CNRT R NON-FINAL ACTION WRITTEN
Jan 10, 2022 DOCK D ASSIGNED TO EXAMINER
Dec 13, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 005
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; nutritional supplements, namely, probiotic compositions; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's Disease in which inflammation is present both in the small intestine and in the colon; dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria; probiotic and nutritional and dietary supplements; food supplements containing probiotic compositions; human food supplements containing probiotic compositions; animal food products containing probiotic compositions; animal nutritional supplements containing probiotic compositions

Active Deadlines

Examiner's Amendment Completed
Due: Jul 29, 2022 Overdue

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ABSORB"